Published: Jan 11, 2022
On January 10, as reported by Indonesian National Agency of Drug and Food Control (BPOM), adenovirus vector COVID-19 vaccine (KCONECAVAC) manufactured by Shenzhen Kangtai Biological Products Co., Ltd. had been approved for emergency use authorization (EUA) of homologous booster dose.
View original source:
https://setkab.go.id/en/bpom-issues-emergency-use-authorization-for-five-booster-vaccines/?utm_source=rss&utm_medium=rss&utm_campaign=bpom-issues-emergency-use-authorization-for-five-booster-vaccines
https://www.pom.go.id/new/view/more/pers/635/Badan-POM-Resmikan-Vaksin-COVID-19-Dosis-Booster-Lanjutan-di-Indonesia.html
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
With global push for COVID-19 vaccines, China aims to win friends and cut deals